GCP
AMGN icon

Gill Capital Partners’s Amgen AMGN Stock Holding History

Gill Capital Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.8K Buy
+42
New +$15K ﹤0.01% 409

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Gill Capital Partners's AMGN Position: Q1 2026 in Review

Gill Capital Partners opened a new position in Amgen (AMGN) in Q1 2026: 42 shares worth $14.8K. The stake represents ﹤0.01% of the portfolio and ranks #409 among its holdings.

3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Gill Capital Partners held 42 shares of Amgen worth $14.8K as of Q1 2026.
  • Amgen was a new Gill Capital Partners position in Q1 2026.
  • Amgen made up ﹤0.01% of Gill Capital Partners's portfolio in Q1 2026, its #409 holding.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Gill Capital Partners's 13F filing for Q1 2026, filed 13 Apr 2026.